9500 diseases unmet.

50 drugs per year.

We can do better for patients.

A thoughtful evolution in drug development is here, now.

We develop technology that accelerates and de-risks pharmaceutical research and development

Our mission is to eliminate inaccuracy and waste when translating drug candidates to clinical trials using AI-driven, multi-disciplinary quantitative methods that predict patient outcomes.

Get Started

Learn more

VeriSIM Life | Drug Discovery & Development Technology

What if?

The lead compound with most confidence could be identified early

You know which drug candidates not to pursue further

Resources, dollars and expertise were allocated only to the promising candidates

You could save years of back and forth with regulators when trying to get a drug to market

Introducing a first-in-class decision engine that enables discovery and R&D de-risking, unlike anything you’ve worked with before.

What is BIOiSIM?

Inferential search space of 1 billion drug-like compounds

Explore the BIOiSIM platform

10 billion network effects spawned in deep learning algorithms

Explore the BIOiSIM platform

800 billion total potential simulation scenarios computational capacity

Explore the BIOiSIM platform

1.5 million real and robust validation simulations

Explore the BIOiSIM platform

AI-powered predictions based on structure-only inputs are 82% more accurate than mechanistic non-informed tools

Explore the BIOiSIM platform

Inferential search space of 1 billion drug-like compounds

Explore the BIOiSIM platform

10 billion network effects spawned in deep learning algorithms

Explore the BIOiSIM platform

800 billion total potential simulation scenarios computational capacity

Explore the BIOiSIM platform

1.5 million real and robust validation simulations

Explore the BIOiSIM platform

AI-powered predictions based on structure-only inputs are 82% more accurate than mechanistic non-informed tools

Explore the BIOiSIM platform

> Touch icons see more BIOiSIM features

Inferential search space of 1 billion drug-like compounds

Explore the BIOiSIM platform

10 billion network effects spawned in deep learning algorithms

Explore the BIOiSIM platform

800 billion total potential simulation scenarios computational capacity

Explore the BIOiSIM platform

1.5 million real and robust validation simulations

Explore the BIOiSIM platform

AI-powered predictions based on structure-only inputs are 82% more accurate than mechanistic non-informed tools

Explore the BIOiSIM platform

Trusted by leaders in pharmaceutical research and development

See testimonials

BIOiSIM-accelerated assets in pipeline

Our service offerings deliver insights for pharmaceutical companies, biotechs, and academic & research institutions. We also partner in risk-sharing collaborations to develop promising drugs.

PulmoSIM Therapeutics, a wholly-owned subsidiary of VeriSIM Life, identifies licensable candidates for preclinical translation and out-licensing to commercialization partners.

Learn how we work with customers and partners

Making a difference

Addressing the unmet needs of patients everywhere is our passion. Are you motivated by ownership in your work and a mission to make a difference? Do you embrace diversity? Is continuous learning part of your DNA? This is what drives the team at VeriSIM Life every day. Learn more about our mission and make up.

Our values

Open positions

We develop technology that accelerates and de-risks pharmaceutical research and development

What if?

Introducing a first-in-class decision engine that enables discovery and R&D de-risking, unlike anything you’ve worked with before.

Inferential search space of 1 billion drug-like compounds

10 billion network effects spawned in deep learning algorithms

800 billion total potential simulation scenarios computational capacity

1.5 million real and robust validation simulations

AI-powered predictions based on structure-only inputs are 82% more accurate than mechanistic non-informed tools

Inferential search space of 1 billion drug-like compounds

10 billion network effects spawned in deep learning algorithms

800 billion total potential simulation scenarios computational capacity

1.5 million real and robust validation simulations

AI-powered predictions based on structure-only inputs are 82% more accurate than mechanistic non-informed tools

Inferential search space of 1 billion drug-like compounds

10 billion network effects spawned in deep learning algorithms

800 billion total potential simulation scenarios computational capacity

1.5 million real and robust validation simulations

AI-powered predictions based on structure-only inputs are 82% more accurate than mechanistic non-informed tools

Trusted by leaders in pharmaceutical research and development

BIOiSIM-accelerated assets in pipeline

Making a difference

News and events